| Ritleng®+ is FCI’s latest autostable bicanalicular nasolacrimal intubation indicated for epiphora, canalicular pathologies, congenital lacrimal duct obstruction and dacryocystorhinostomy (DCR). |
Showing 1 - 8 of 56 resources found
FCI offers innovative solutions essential in the treatment of dry eye, lacrimal, eyelid, and orbit indications.
FCI Vitreoretinal Catalog
FCI Cataract Catalog - USA
FCI Ophthalmics Dry Eye Catalog
FCI Ophthalmics Dry Eye Patient Brochure
LacriJet® is FCI latest and exclusive preloaded and self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.
FCI Super Grip Forceps are specially designed to grasp the fibrous membranes that are difficult to catch with traditional instruments. A 360° actuation handle provides easy and precise maneuverability.